Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
ThesisAdyen: the setup is constructive — Processed volume growth rate (target: 20-30% annually) - particularly North American enterprise wins where take-rates…
★ Analysts see FY2026 revenue reaching $3.3B — +24.8% growth in a single year.
Why Revenue Could Accelerate
01Processed volume growth rate (target: 20-30% annually) - particularly North American enterprise wins where take-rates are 30% higher than European average
02Net revenue take-rate (basis points captured per €100 processed) - compression from payment method mix shift (wallets/bank transfers lower margin than cards) versus expansion from value-added services
03EBITDA margin trajectory - investor focus on balancing growth investment (sales hiring, geographic expansion) versus profitability demonstration after 2023 margin reset
04Large merchant wins and churn - single enterprise client can represent $5-15B in annual volume; losses to competitors like Stripe or Checkout.com drive 5-10% stock moves
growth - Investors pay 13x sales for 20%+ revenue growth and 40%+ margins, betting on payments infrastructure market share gains…
Rising rates create dual impact: (1) Negative valuation multiple compression - high-growth fintech trades at 25-40% discount to historical…
Watch on earnings: US and EU e-commerce sales growth rates (proxy for addressable market expansion), Stripe/Checkout.com funding rounds and valuation trends (competitive intensity signal), Card network (Visa/Mastercard) cross-border volume trends (leading indicator for Adyen's international processing).
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $3.3B to $4.1B as processed volume growth rate (target: 20-30% annually) - particularly north american enterprise wins where take-rates.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
